Institute for International Research

Dear Colleague,

Why Attend This SOX Event?

In our research with professionals from pharmaceutical and biotech companies, 90% of you voiced a need to move towards a risk assessment approach to SOX to achieve cost savings and increased efficiency. Look no further than IIR's Sarbanes-Oxley Compliance Event tailored specifically for pharmaceutical and biotech companies. The SEC and PCAOB address your most pressing concerns and deliver the latest guidelines you need to know to implement a risk-based approach to Sarbanes-Oxley. Hear case studies directly from industry leaders on the most efficient methods for implementing and maintaining Sarbanes-Oxley.

What Will You Learn?

This event delivers 14 sessions to save your company time and money including:

• Learn the latest regulatory guidelines from the SEC and PCAOB on how to use a risk based approach for management and auditors
  
• Hear from the IRS – The latest FIN 48 developments to further improve your risk analysis
  
• Manage risk and compliance across the entire business to achieve a unified organization
  
• How to effectively conduct a risk assessment to accurately identify the necessary controls
  
• Integrate IT and Financial controls to achieve a broader governance risk compliance
  
• Automate your SOX process with the latest technology to achieve greater efficiency
  
• Save your company from costly mistakes through the detection and prevention of non-compliant behavior

Networking!

We added more time for Q&A and networking to ensure that your agenda of questions get answered. Join us on November 29th to hear the latest developments from the SEC, PCAOB, IRS, and best practices from industry leaders. We look forward to seeing you in Philadelphia!

Sincerely,

Jennie Friedlich
Event Director, Pharmaceutical Division
Institute for International Research

Valerie Bowling
Divisional Manager, Pharmaceutical Division
Institute for International Research